Medtronic CAO reports stock grant and tax shares
Medtronic plc Chief Accounting Officer Denise L. Blomquist reported routine equity compensation activity.
Rhea-AI Filing Summary
Medtronic plc Chief Accounting Officer Denise L. Blomquist reported routine equity compensation activity. On April 27, 2026, she acquired 1,508 Ordinary Shares at $0.00 per share as a grant of restricted stock units that vest in three annual installments beginning one year from the grant date.
On April 28, 2026, 318 Ordinary Shares were disposed of at $81.90 per share, representing shares withheld to pay taxes upon vesting of previously granted restricted stock units, rather than an open-market sale. After these transactions, she directly owned 13,262 Ordinary Shares, including 106 shares acquired through dividend reinvestment since her last report.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Ordinary Shares | 318 | $81.90 | $26K |
| Grant/Award | Ordinary Shares | 1,508 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represents restricted stock units that vest in three annual installments beginning one year from the date of grant.
- F2. Includes 106 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- F3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
Key Figures
Key Terms
restricted stock units financial
dividend reinvestment financial
tax-withholding disposition financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Medtronic (MDT) report for Denise Blomquist?
What are the vesting terms of the new Medtronic (MDT) restricted stock units?
Did Medtronic’s Chief Accounting Officer make any open-market trades in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.